{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:27Z","timestamp":1790742507664,"version":"4.1.0"},"reference-count":322,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.npep.2023.102388","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:48:38Z","timestamp":1698148118000},"page":"102388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Cross talk about the role of Neuropeptide Y in CNS disorders and diseases"],"prefix":"10.1016","volume":"102","author":[{"given":"Rajeshwari","family":"Bale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2023.102388_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ahg.12211","article-title":"Evaluation of a role for NPY and NPY2R in the Pathogenesis of obesity by mutation and copy number variation analysis in obese children and adolescents","volume":"82","author":"Aerts","year":"2018","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.npep.2023.102388_bb0010","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1634\/stemcells.2008-0056","article-title":"Neuropeptide Y promotes neurogenesis in murine subventricular zone","volume":"26","author":"Agasse","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.npep.2023.102388_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.aprim.2021.102208","article-title":"Migraine review for general practice","volume":"54","author":"Aguilar-Shea","year":"2022","journal-title":"Aten. primaria"},{"key":"10.1016\/j.npep.2023.102388_bb0020","first-page":"232","article-title":"Relationship between alcohol dependence and Neuropeptide Y (NPY) gene promoter polymorphisms in A Turkish sample","volume":"31","author":"Akel Bilgi\u00e7","year":"2020","journal-title":"Turk Psikiyatri Derg."},{"key":"10.1016\/j.npep.2023.102388_bb0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bph.12445","article-title":"The Concise Guide to PHARMACOLOGY 2013\/14: G protein-coupled receptors","volume":"170","author":"Alexander","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0030","article-title":"Alpha calcitonin Gene-related Peptide, Neuropeptide Y, and substance P as biomarkers for diagnosis and disease activity and severity in multiple sclerosis","author":"Al-Keilani","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.npep.2023.102388_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-8993(85)91632-4","article-title":"Dissociation of neuropeptide Y and somatostatin in Parkinson\u2019s disease","volume":"337","author":"Allen","year":"1985","journal-title":"Brain Res."},{"issue":"Pt 1","key":"10.1016\/j.npep.2023.102388_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/brain\/109.1.143","article-title":"Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson\u2019s disease?","volume":"109","author":"Allen","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.npep.2023.102388_bb0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000117347","article-title":"Cerebrospinal fluid neuropeptide Y in Alzheimer\u2019s disease","volume":"30","author":"Alom","year":"1990","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcp.30944","article-title":"GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant-like effects involving BDNF actions","volume":"238","author":"Alvarez-Contino","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.npep.2023.102388_bb0055","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2023.","DOI":"10.1176\/appi.books.9780890424865"},{"key":"10.1016\/j.npep.2023.102388_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm90030050","article-title":"Antidepressant effect of Neuropeptide Y in models of acute and chronic stress","volume":"90","author":"Andriushchenko","year":"2022","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.npep.2023.102388_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yhbeh.2015.05.018","article-title":"Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice","volume":"73","author":"Antunes","year":"2015","journal-title":"Horm. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb0070","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0196-9781(99)00155-2","article-title":"Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice\u2606","volume":"20","author":"Asakawa","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb0075","first-page":"386","article-title":"Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats","volume":"25","author":"Badia-Elder","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0080","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1530-0277.2003.tb04413.x","article-title":"Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats","volume":"27","author":"Badia-Elder","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.peptides.2006.07.028","article-title":"Neuropeptide Y modulation of ethanol intake: effects of ethanol drinking history and genetic background","volume":"28","author":"Badia-Elder","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb0090","doi-asserted-by":"crossref","first-page":"26762","DOI":"10.1074\/jbc.270.45.26762","article-title":"Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, Neuropeptide Y, and Peptide YY (*)","volume":"270","author":"Bard","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbr.2016.01.015","article-title":"Neuropeptide Y response to alcohol is altered in nucleus accumbens of mice selectively bred for drinking to intoxication","volume":"302","author":"Barkley-Levenson","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0100","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1007\/s00216-020-02825-z","article-title":"Determination of neuropeptide Y Y1 receptor antagonist BIBP 3226 and evaluation of receptor expression based on liquid chromatography coupled with tandem mass spectrometry","volume":"412","author":"Barreiros","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.npep.2023.102388_bb0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.410200303","article-title":"Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer\u2019s disease","volume":"20","author":"Beal","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/syn.890020415","article-title":"Somatostatin and neuropeptide Y immunoreactivity in Parkinson\u2019s disease dementia with Alzheimer\u2019s changes","volume":"2","author":"Beal","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2023.102388_bb0120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ana.410230606","article-title":"Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington\u2019s disease","volume":"23","author":"Beal","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.it.2004.08.005","article-title":"More sympathy for autoimmunity with neuropeptide Y?","volume":"25","author":"Bedoui","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.npep.2023.102388_bb0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000345258.18071.54","article-title":"Neuropeptide Y: its multiple effects in the CNS and potential clinical significance","volume":"72","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2023.102388_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pbb.2010.10.002","article-title":"Neuropeptide Y (NPY)-induced reductions in alcohol intake during continuous access and following alcohol deprivation are not altered by restraint stress in alcohol-preferring (P) rats","volume":"97","author":"Bertholomey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/01.ALC.0000075827.74538.FE","article-title":"Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain","volume":"27","author":"Bison","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0145","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2023.102388_bb0150","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1073\/pnas.89.6.2350","article-title":"Strong evolutionary conservation of neuropeptide Y: sequences of chicken, goldfish, and Torpedo marmorata DNA clones","volume":"89","author":"Blomqvist","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2023.102388_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110699","article-title":"Adolescent binge-like alcohol exposure dysregulates NPY and CGRP in rats: behavioural and immunochemical evidence","volume":"123","author":"Brancato","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0160","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1742-4658.2006.05221.x","article-title":"Neuropeptide Y-family receptors Y6 and Y7 in chicken","volume":"273","author":"Brom\u00e9e","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.npep.2023.102388_bb0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-199504000-00001","article-title":"Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures","volume":"6","author":"Broqua","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.npep.2023.102388_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0893-133X(00)00231-1","article-title":"Neuropeptide Y Y1 and Y2 Receptor mRNA Expression in the Prefrontal Cortex of Psychiatric Subjects","volume":"25","author":"Caberlotto","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2023.102388_bb0180","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1460-9568.1997.tb01476.x","article-title":"Localization of Neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum","volume":"9","author":"Caberlotto","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0185","first-page":"97","article-title":"Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family","volume":"6","author":"Cabrele","year":"2000","journal-title":"J. Pept. Sci. Off. Publ. Eur. Pept. Soc."},{"key":"10.1016\/j.npep.2023.102388_bb0190","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.npep.2023.102388_bb0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-328X(02)00555-7","article-title":"Increased neuropeptide Y mRNA expression in striatum in Parkinson\u2019s disease","volume":"110","author":"Cannizzaro","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuron.2004.10.009","article-title":"Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice","volume":"44","author":"Cannon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2023.102388_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107669","article-title":"Effects of Y1 receptor agonist on the pancreatic islet of diet-induced obese and diabetic mice","volume":"34","author":"Carapeto","year":"2020","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.npep.2023.102388_bb0210","series-title":"Nanotechnology and the Brain","first-page":"1","article-title":"Chapter One - recent trends in nanotechnology toward CNS diseases: lipid-based nanoparticles and exosomes for targeted therapeutic delivery","author":"Cardoso","year":"2016"},{"key":"10.1016\/j.npep.2023.102388_bb0215","first-page":"E74","article-title":"Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system","volume":"265","author":"Castan","year":"1993","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.npep.2023.102388_bb0220","first-page":"R213","article-title":"Peptide YY and the Y2 agonist PYY-(13-36) inhibit neurons of the dorsal motor nucleus of the vagus","volume":"273","author":"Chen","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2023.102388_bb0225","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.peptides.2006.07.034","article-title":"Regulation of hypothalamic NPY by diet and smoking","volume":"28","author":"Chen","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2008.07.008","article-title":"A protein kinase C activity localized to neuropeptide Y-like neurons mediates ethanol intoxication in Drosophila melanogaster","volume":"156","author":"Chen","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2023.102388_bb0235","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1158\/1078-0432.CCR-18-2912","article-title":"Depression-induced Neuropeptide Y secretion promotes prostate cancer growth by recruiting myeloid cells","volume":"25","author":"Cheng","year":"2019","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.npep.2023.102388_bb0240","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","article-title":"The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0245","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.1523\/JNEUROSCI.3127-13.2014","article-title":"Single-cell imaging of bioenergetic responses to neuronal excitotoxicity and oxygen and glucose deprivation","volume":"34","author":"Connolly","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autneu.2006.10.005","article-title":"Neuropeptide Y receptors; antisecretory control of intestinal epithelial function","volume":"133","author":"Cox","year":"2007","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pbb.2011.04.005","article-title":"Prolonged chronic ethanol exposure alters neuropeptide Y and corticotropin-releasing factor levels in the brain of adult Wistar rats","volume":"99","author":"Criado","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000323468","article-title":"Neuroprotective effect of neuropeptide Y against \u03b2-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production","volume":"8","author":"Croce","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.npep.2023.102388_bb0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","article-title":"NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?","volume":"376","author":"Croce","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.npep.2023.102388_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroscience.2004.11.037","article-title":"Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats","volume":"132","author":"Crowley","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2023.102388_bb0275","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X1304150831123535","article-title":"Editorial: a systematic review of depression","author":"Cui","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0280","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","article-title":"Increased cell proliferation and neurogenesis in the adult human Huntington\u2019s disease brain","volume":"100","author":"Curtis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2023.102388_bb0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2006.02.009","article-title":"Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment","volume":"1083","author":"D\u2019Este","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-0115(02)00034-4","article-title":"Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist","volume":"106","author":"Daniels","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2023.102388_bb0295","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neuron.2004.05.004","article-title":"Natural variation in the npr-1 gene modifies ethanol responses of wild strains of C. elegans","volume":"42","author":"Davies","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2023.102388_bb0300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington\u2019s disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fneur.2017.00485","article-title":"Peripheral oxidative stress biomarkers in spinocerebellar ataxia Type 3\/Machado-Joseph disease","volume":"8","author":"de Assis","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0310","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0315","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fncel.2018.00459","article-title":"Neuro-immune hemostasis: homeostasis and diseases in the central nervous system","volume":"12","author":"De Luca","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0320","first-page":"15","article-title":"Anxiety","volume":"30","author":"Dean","year":"2016","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.npep.2023.102388_bb0325","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nbd.2009.02.017","article-title":"Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice","volume":"34","author":"Decressac","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2023.102388_bb0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2010.07.022","article-title":"Neuropeptide Y modifies the disease course in the R6\/2 transgenic model of Huntington\u2019s disease","volume":"226","author":"Decressac","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0335","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.neurobiolaging.2011.06.018","article-title":"Neuroprotection by neuropeptide Y in cell and animal models of Parkinson\u2019s disease","volume":"33","author":"Decressac","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.npep.2023.102388_bb0340","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.ijo.0802435","article-title":"A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor","volume":"28","author":"Della-Zuana","year":"2004","journal-title":"Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.npep.2023.102388_bb0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2013.03.018","article-title":"NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell","volume":"247","author":"Desai","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0350","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.neuroscience.2014.07.062","article-title":"Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice","volume":"277","author":"Desai","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2023.102388_bb0355","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI131919","article-title":"Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer","volume":"130","author":"Dietrich","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2023.102388_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110349","article-title":"Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: evidence from preclinical studies","volume":"111","author":"Domin","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110349","article-title":"Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: evidence from preclinical studies","volume":"111","author":"Domin","year":"2021","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0370","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/acschemneuro.9b00082","article-title":"Characterization of the brain penetrant Neuropeptide Y Y2 receptor Antagonist SF-11","volume":"10","author":"Domin","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b2(1-40)) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0380","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1093\/hmg\/ddv271","article-title":"Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease","volume":"24","author":"Duarte-Neves","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2023.102388_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82339-5","article-title":"Neuropeptide Y (NPY) intranasal delivery alleviates Machado\u2013Joseph disease","volume":"11","author":"Duarte-Neves","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2023.102388_bb0390","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41598-021-82339-5","article-title":"Neuropeptide Y (NPY) intranasal delivery alleviates Machado\u2013Joseph disease","volume":"11","author":"Duarte-Neves","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2023.102388_bb0395","series-title":"Chapter 11.8 Vitamins 271\u2013294","author":"Dumont","year":"1987"},{"key":"10.1016\/j.npep.2023.102388_bb0400","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1523\/JNEUROSCI.18-15-05565.1998","article-title":"Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain","volume":"18","author":"Dumont","year":"1998","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0405","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/exnr.2000.7446","article-title":"Expression of a Novel Neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain","volume":"165","author":"Durkin","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0410","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnagi.2018.00297","article-title":"Somatostatin and Neuropeptide Y in cerebrospinal fluid: correlations with amyloid Peptides A\u03b2(1-42) and Tau proteins in elderly patients with mild cognitive impairment","volume":"10","author":"Duron","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0415","doi-asserted-by":"crossref","first-page":"364","DOI":"10.55782\/ane-2015-2041","article-title":"Antidepressant-like and anxiolytic-like effects of mild hypobaric hypoxia in mice: possible involvement of neuropeptide Y","volume":"75","author":"Duszczyk","year":"2015","journal-title":"Acta Neurobiol. Exp. (Wars)."},{"key":"10.1016\/j.npep.2023.102388_bb0420","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/156802607782341037","article-title":"Relevance of neuropeptide Y (NPY) in psychiatry","volume":"7","author":"Eaton","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb0425","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.npep.2009.08.007","article-title":"Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake","volume":"43","author":"Edelsbrunner","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/jcbfm.1987.7","article-title":"Nerve fibers containing neuropeptide Y in the cerebrovascular bed: immunocytochemistry, radioimmunoassay, and vasomotor effects","volume":"7","author":"Edvinsson","year":"1987","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.npep.2023.102388_bb0435","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1468-2982.1994.1402088.x","article-title":"Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries","volume":"14","author":"Edvinsson","year":"1994","journal-title":"Cephalalgia"},{"key":"10.1016\/j.npep.2023.102388_bb0440","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/j.1530-0277.1998.tb03979.x","article-title":"Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure","volume":"22","author":"Ehlers","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0445","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2016.12.003","article-title":"Preclinical Alzheimer\u2019s disease: a systematic review of the cohorts underlying the concept","volume":"13","author":"Epelbaum","year":"2017","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.npep.2023.102388_bb0450","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/oby.2007.620","article-title":"Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss","volume":"15","author":"Erondu","year":"2007","journal-title":"Obesity (Silver Spring)."},{"key":"10.1016\/j.npep.2023.102388_bb0455","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","article-title":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease","volume":"302","author":"Fatoba","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0460","doi-asserted-by":"crossref","first-page":"41921","DOI":"10.1074\/jbc.M110.164020","article-title":"Neuropeptide y modulation of interleukin-1\u03b2 (IL-1\u03b2)-induced nitric oxide production in microglia","volume":"285","author":"Ferreira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb0465","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0196-9781(02)00133-X","article-title":"Functional mapping of NPY\/PYY receptors in rat and human gastro-intestinal tract","volume":"23","author":"Ferrier","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb0470","first-page":"4","article-title":"Sex differences in the neurobiology of alcohol use disorder","volume":"40","author":"Flores-Bonilla","year":"2020","journal-title":"Alcohol Res."},{"key":"10.1016\/j.npep.2023.102388_bb0475","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2125.2012.04474.x","article-title":"Future pharmacological treatments for substance use disorders","volume":"77","author":"Forray","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0480","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(95)00834-D","article-title":"Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine\u2019s effects on energy balance","volume":"694","author":"Frankish","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0485","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0447.1991.tb05539.x","article-title":"In the temporal cortex of the schizophrenic brains, galanin, AVP, NPY and PYY were significantly reduced YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics","volume":"83","author":"Frederiksen","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.npep.2023.102388_bb0490","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1468-2982.1994.1401047.x","article-title":"Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura","volume":"14","author":"Friberg","year":"1994","journal-title":"Cephalalgia"},{"key":"10.1016\/j.npep.2023.102388_bb0495","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1073\/pnas.87.1.182","article-title":"[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist","volume":"87","author":"Fuhlendorff","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2023.102388_bb0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.npep.2018.05.006","article-title":"An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice","volume":"70","author":"Fukasaka","year":"2018","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0505","first-page":"82","article-title":"Neuropeptide deficits in schizophrenia vs","volume":"39","author":"Gabriel","year":"1996","journal-title":"Alzheimer\u2019s disease cerebral cortex. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0510","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.1994.hed3401035.x","article-title":"Neuropeptide Y in juvenile migraine and tension-type headache","volume":"34","author":"Gallai","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.npep.2023.102388_bb0515","series-title":"Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. (New York, N.Y.)","first-page":"7","article-title":"Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications","volume":"218","author":"Gehlert","year":"1998"},{"key":"10.1016\/j.npep.2023.102388_bb0520","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0525","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.npep.2012.08.001","article-title":"Neuropeptide Y (NPY) in the extended amygdala is recruited during the transition to alcohol dependence","volume":"46","author":"Gilpin","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0530","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.pbb.2008.04.006","article-title":"Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking","volume":"90","author":"Gilpin","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb0535","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2011.02.004","article-title":"Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence","volume":"69","author":"Gilpin","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0540","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0545","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/jnc.12052","article-title":"Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment","volume":"123","author":"Gon\u00e7alves","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2023.102388_bb0550","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/j.1460-9568.2012.08232.x","article-title":"Protective role of neuropeptide Y Y\u2082 receptors in cell death and microglial response following methamphetamine injury","volume":"36","author":"Gon\u00e7alves","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0555","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(93)90217-B","article-title":"Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus; a silver degeneration and immunocytochemical study","volume":"616","author":"Goodman","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0560","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/brain\/awt084","article-title":"Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism","volume":"136","author":"Goto","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.npep.2023.102388_bb0565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.npep.2015.09.010","article-title":"The role of NPY in learning and memory","volume":"55","author":"G\u00f8tzsche","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0570","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nbd.2011.08.012","article-title":"Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures","volume":"45","author":"G\u00f8tzsche","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2023.102388_bb0575","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/1097-4547(20000815)61:4<458::AID-JNR13>3.0.CO;2-I","article-title":"Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum","volume":"61","author":"Gruber","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0580","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.npep.2023.102388_bb0585","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/1028415X.2018.1465713","article-title":"High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome","volume":"22","author":"Hassan","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0590","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.domaniend.2008.01.004","article-title":"Patterns of gene expression in pig adipose tissue: Insulin-like growth factor system proteins, neuropeptide Y (NPY), NPY receptors, neurotrophic factors and other secreted factors","volume":"35","author":"Hausman","year":"2008","journal-title":"Domest. Anim. Endocrinol."},{"key":"10.1016\/j.npep.2023.102388_bb0595","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.ALC.0000164375.16838.F3","article-title":"Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL\/6J and low ethanol drinking DBA\/2J inbred mouse strains","volume":"29","author":"Hayes","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0600","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0605","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.npep.2023.102388_bb0610","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0167-0115(92)90514-U","article-title":"Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test","volume":"41","author":"Heilig","year":"1992","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2023.102388_bb0615","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2011.11.008","article-title":"Neuropeptide Y (NPY) in the central nucleus of the amygdala (CeA) does not affect ethanol-reinforced responding in binge-drinking, nondependent rats","volume":"101","author":"Henderson","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb0620","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10571-011-9793-z","article-title":"NPY and stress 30 years later: the peripheral view","volume":"32","author":"Hirsch","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.npep.2023.102388_bb0625","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2012.08.005","article-title":"Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis","volume":"46","author":"Holzer","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0630","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1471-4159.2005.03057.x","article-title":"Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus","volume":"93","author":"Howell","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2023.102388_bb0635","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0893-133X(02)00363-9","article-title":"Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes","volume":"27","author":"Husum","year":"2002","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0640","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.pnpbp.2003.11.008","article-title":"Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia","volume":"28","author":"Ikeda","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0645","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0278-5846(99)00102-5","article-title":"Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics","volume":"24","author":"Iritani","year":"2000","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0650","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0304-3940(03)00718-3","article-title":"Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans","volume":"347","author":"Itokawa","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb0655","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(95)00179-O","article-title":"Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors","volume":"278","author":"Jacques","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0660","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1210\/endo.140.11.7107","article-title":"Evidence that stimulation of two modalities of pituitary luteinizing hormone release in Ovarian Steroid-Primed Ovariectomized rats may involve Neuropeptide Y Y1 and Y4 Receptors1","volume":"140","author":"Jain","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2023.102388_bb0665","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-8993(02)04122-7","article-title":"Nicotine administration decreases neuropeptide Y expression and increases leptin receptor expression in the hypothalamus of food-deprived rats","volume":"964","author":"Jang","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0670","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/schbul\/sbq135","article-title":"DISC1 in schizophrenia: genetic mouse models and human genomic imaging","volume":"37","author":"Johnstone","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.npep.2023.102388_bb0675","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0026-895X(24)12241-9","article-title":"A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814","volume":"59","author":"Kanatani","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0680","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-981-15-1792-1_23","article-title":"Exercise and Anxiety","volume":"1228","author":"Kandola","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.npep.2023.102388_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(00)01730-4","article-title":"Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat","volume":"298","author":"Kane","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb0690","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbr.2009.10.029","article-title":"Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency","volume":"207","author":"Karl","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0695","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.npep.2009.12.008","article-title":"Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor","volume":"44","author":"Karl","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0700","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0028-3908(99)00199-9","article-title":"Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304","volume":"39","author":"Kask","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102388_bb0705","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(96)00838-2","article-title":"Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam","volume":"317","author":"Kask","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0710","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-8993(98)00076-6","article-title":"Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats","volume":"788","author":"Kask","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0715","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(01)00768-3","article-title":"Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat","volume":"414","author":"Kask","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0720","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2016.11.061","article-title":"Neuropeptide Y, resilience, and PTSD therapeutics","volume":"649","author":"Kautz","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb0725","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.npep.2023.102388_bb0730","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cne.903090408","article-title":"Peptidergic and serotoninergic innervation of the rat dura mater","volume":"309","author":"Keller","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0735","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0304-3940(86)90174-6","article-title":"Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence","volume":"66","author":"Kerkerian","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb0740","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drugalcdep.2015.04.008","article-title":"Substance use and treatment of substance use disorders in a community sample of transgender adults","volume":"152","author":"Keuroghlian","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.npep.2023.102388_bb0745","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2015.12.011","article-title":"The y6 receptor suppresses bone resorption and stimulates bone formation in mice via a suprachiasmatic nucleus relay","volume":"84","author":"Khor","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.npep.2023.102388_bb0750","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1097\/00001756-200011090-00023","article-title":"Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus","volume":"11","author":"Kinoshita","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.npep.2023.102388_bb0755","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00109-013-1092-3","article-title":"Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R","volume":"92","author":"Kloster","year":"2014","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.npep.2023.102388_bb0760","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(95)11973-Z","article-title":"Plasma neuropeptide Y is reduced in patients with Alzheimer\u2019s disease","volume":"198","author":"Koide","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb0765","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2014.01.004","article-title":"Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system","volume":"262","author":"Kotagale","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0770","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410230202","article-title":"Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer\u2019s disease","volume":"23","author":"Kowall","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0775","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J. Huntingtons. Dis."},{"key":"10.1016\/j.npep.2023.102388_bb0780","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2202-10-95","article-title":"Gene expression changes following extinction testing in a heroin behavioral incubation model","volume":"10","author":"Kuntz-Melcavage","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0785","first-page":"12","article-title":"Anxiety and depression: What do we know of Neuropeptides?","author":"Kupcova","year":"2022","journal-title":"Behav. Sci. (Basel, Switzerland)"},{"key":"10.1016\/j.npep.2023.102388_bb0790","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1567-133X(01)00003-5","article-title":"Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder","volume":"1","author":"Kuromitsu","year":"2001","journal-title":"Brain Res. Gene Expr. Patterns"},{"key":"10.1016\/j.npep.2023.102388_bb0795","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/1871527311312050010","article-title":"Neuropeptide systems and schizophrenia","volume":"12","author":"LaCrosse","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.npep.2023.102388_bb0800","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0805","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.npep.2023.102388_bb0810","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cellsig.2015.03.016","article-title":"Neuropeptide Y receptor mediates activation of ERK1\/2 via transactivation of the IGF receptor","volume":"27","author":"Lecat","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.npep.2023.102388_bb0815","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-0115(98)00054-8","article-title":"Is there really an NPY Y3 receptor?","volume":"75\u201376","author":"Lee","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2023.102388_bb0820","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejcb.2018.04.003","article-title":"Neuropeptide Y mitigates ER stress-induced neuronal cell death by activating the PI3K-XBP1 pathway","volume":"97","author":"Lee","year":"2018","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.npep.2023.102388_bb0825","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cne.1420","article-title":"Localization and characterization of NPY\/PYY receptors in rat frontoparietal cortex during development","volume":"442","author":"Leroux","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(00)02283-6","article-title":"Nicotine administration enhances NPY expression in the rat hypothalamus","volume":"867","author":"Li","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0835","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.peptides.2010.06.011","article-title":"Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake","volume":"31","author":"Li","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb0840","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.06.010","article-title":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways","volume":"48","author":"Lian","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.npep.2023.102388_bb0845","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2013.01.008","article-title":"Neurons as targets for T cells in the nervous system","volume":"36","author":"Liblau","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0850","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.npep.2004.05.005","article-title":"NPY and Y receptors: lessons from transgenic and knockout models","volume":"38","author":"Lin","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0855","doi-asserted-by":"crossref","DOI":"10.1111\/bph.16192","article-title":"G\u03b2\u03b3 subunit signalling underlies neuropeptide Y-stimulated vasoconstriction in rat mesenteric and coronary arteries","author":"Lin","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0860","doi-asserted-by":"crossref","first-page":"29123","DOI":"10.1074\/jbc.270.49.29123","article-title":"Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY (*)","volume":"270","author":"Lundell","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb0865","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbr.2014.02.039","article-title":"The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats","volume":"266","author":"Ma","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0870","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2174\/156802607782341028","article-title":"NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs","volume":"7","author":"MacNeil","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb0875","first-page":"327","article-title":"Phenotypic alterations in Hippocampal NPY- and PV-Expressing interneurons in a presymptomatic transgenic mouse model of Alzheimer\u2019s Disease","volume":"8","author":"Mahar","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0880","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2008.06.023","article-title":"Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats","volume":"194","author":"Maric","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0885","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.peptides.2008.11.006","article-title":"Neuropeptide Y augments cocaine self-administration and cocaine-induced hyperlocomotion in rats","volume":"30","author":"Maric","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb0890","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0006-8993(90)90082-M","article-title":"Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer\u2019s disease","volume":"519","author":"Martel","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0895","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson\u2019s disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural Transm. \u2013 Park Dis. Dement. Sect."},{"key":"10.1016\/j.npep.2023.102388_bb0900","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415598292","article-title":"Activation of Neuropeptide Y receptors modulates retinal Ganglion cell physiology and exerts neuroprotective actions in vitro","volume":"7","author":"Martins","year":"2015","journal-title":"ASN Neuro"},{"key":"10.1016\/j.npep.2023.102388_bb0905","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.14541","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2023.102388_bb0910","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.410410418","article-title":"Cortical peptide changes in Huntington\u2019s disease may be independent of striatal degeneration","volume":"41","author":"Mazurek","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb0915","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pbb.2014.12.007","article-title":"Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking","volume":"129","author":"McClintick","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb0920","doi-asserted-by":"crossref","first-page":"4143447","DOI":"10.1155\/2022\/4143447","article-title":"Prognostic and functional analysis of NPY6R in uveal melanoma using bioinformatics","volume":"2022","author":"Mei","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.npep.2023.102388_bb0925","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.31","article-title":"Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression","volume":"3","author":"Melas","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb0930","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(92)91268-J","article-title":"Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen","volume":"593","author":"Midgley","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0935","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(94)90400-6","article-title":"Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions","volume":"251","author":"Midgley","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0940","first-page":"57","article-title":"Neuropeptide levels in Alzheimer\u2019s disease and dementia with frontotemporal degeneration","volume":"30","author":"Minthon","year":"1990","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.npep.2023.102388_bb0945","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/sj.npp.1300900","article-title":"The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats","volume":"31","author":"Misra","year":"2006","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0950","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.bmcl.2012.04.107","article-title":"Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists","volume":"22","author":"Mittapalli","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb0955","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.npep.2016.08.004","article-title":"Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis","volume":"60","author":"Mohammadi","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0960","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb0965","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","article-title":"Role of neuropeptide Y Y\u2081 and Y\u2082 receptors on behavioral despair in a rat model of depression with co-morbid anxiety","volume":"62","author":"Morales-Medina","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102388_bb0970","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:29:2:109","article-title":"Distribution of NPY Y5-like immunoreactivity in the rat brain","volume":"29","author":"Morin","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb0975","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2009.09.057","article-title":"Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice","volume":"627","author":"Moriya","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb0980","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.npep.2016.12.010","article-title":"Neuropeptide Y neuronal network dysfunction in the frontal lobe of a genetic mouse model of schizophrenia","volume":"62","author":"Morosawa","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb0985","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2009.09.014","article-title":"NPY mRNA expression in the prefrontal cortex: Selective reduction in the superficial white matter of subjects with schizoaffective disorder","volume":"115","author":"Morris","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.npep.2023.102388_bb0990","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00003495-199652030-00004","article-title":"The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive","volume":"52","author":"Munglani","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.npep.2023.102388_bb0995","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.705579","article-title":"Intranasal Neuropeptide Y as a potential therapeutic for depressive behavior in the rodent single prolonged stress model in females","volume":"15","author":"Nahvi","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb1000","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0196-9781(97)00298-2","article-title":"Neuropeptide Y produces anxiety via Y2-type receptors","volume":"19","author":"Nakajima","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb1005","author":"NCT00748956"},{"key":"10.1016\/j.npep.2023.102388_bb1010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S1461145711001556","article-title":"Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response","volume":"15","author":"Nikisch","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2019.102001","article-title":"Activation of NPY receptor subtype 1 by [D-His(26)]NPY is sufficient to prevent development of anxiety and depressive like effects in the single prolonged stress rodent model of PTSD","volume":"80","author":"Nwokafor","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0924-977X(99)00003-6","article-title":"Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens","volume":"9","author":"Obuchowicz","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0047-1","article-title":"Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice","volume":"110","author":"Obuchowicz","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.npep.2023.102388_bb1030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb1035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.npep.2012.01.002","article-title":"Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity","volume":"46","author":"Olesen","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1040","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/j.pain.0000000000000571","article-title":"Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine","volume":"157","author":"Oliveira","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.npep.2023.102388_bb1045","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1080\/14656566.2022.2135432","article-title":"Pharmacotherapy for the management of the symptoms of Machado-Joseph Disease","volume":"23","author":"Oliveira","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.npep.2023.102388_bb1050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0035-1565241","article-title":"The effects of antidepressants on Neuropeptide Y in patients with depression and anxiety","volume":"49","author":"Ozsoy","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb1055","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12464","article-title":"Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y","volume":"33","author":"Pain","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1060","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2174\/1570159X19666210906120302","article-title":"Neuroprotective effects of Neuropeptide Y against neurodegenerative disease","volume":"20","author":"Pain","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1065","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.npep.2023.102388_bb1070","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41467-022-28510-6","article-title":"Structural basis of neuropeptide Y signaling through Y1 receptor","volume":"13","author":"Park","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.npep.2023.102388_bb1075","series-title":"Neuropeptide Y Receptors, in: Lennarz, W.J., Lane, M.D.B.T.-E. of B.C. (Eds.)","first-page":"26","author":"Parker","year":"2004"},{"key":"10.1016\/j.npep.2023.102388_bb1080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0707445","article-title":"Neuropeptide Y Y2 receptor in health and disease","volume":"153","author":"Parker","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1085","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel","year":"2014","journal-title":"P T"},{"key":"10.1016\/j.npep.2023.102388_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2013.00005","article-title":"Neuropeptide Y receptors: how to get subtype selectivity","volume":"4","author":"Pedragosa Badia","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.npep.2023.102388_bb1095","doi-asserted-by":"crossref","first-page":"R2299","DOI":"10.1152\/ajpregu.00790.2006","article-title":"ICV NPY Y1 receptor agonist but not Y5 agonist induces torpor-like hypothermia in cold-acclimated Siberian hamsters","volume":"292","author":"Pelz","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2023.102388_bb1100","first-page":"S23","article-title":"Migraine overview and summary of current and emerging treatment options","volume":"25","author":"Peters","year":"2019","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.npep.2023.102388_bb1105","first-page":"287","article-title":"Neuropeptide Y-like immunoreactivity in schizophrenia","volume":"3","author":"Peters","year":"1990","journal-title":"Relationships with clinical measures. Schizophr. Res."},{"key":"10.1016\/j.npep.2023.102388_bb1110","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3346\/jkms.2008.23.6.1027","article-title":"Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors","volume":"23","author":"Piao","year":"2008","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.npep.2023.102388_bb1115","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0196-9781(93)90065-O","article-title":"Neuropeptide Y produces anxiolytic effects in spontaneously hypertensive rats","volume":"14","author":"Pich","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb1120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11095-021-03077-x","article-title":"Rational development of stable PYY(3-36) Peptide Y(2) receptor agonists","volume":"38","author":"Poulsen","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.npep.2023.102388_bb1125","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","article-title":"Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb1130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuropharm.2010.09.016","article-title":"Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas","volume":"60","author":"Quarta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102388_bb1135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2023.102388_bb1140","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.neurobiolaging.2005.09.022","article-title":"Early neuropathology of somatostatin\/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer\u2019s disease","volume":"27","author":"Ramos","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.npep.2023.102388_bb1145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-4328(02)00374-1","article-title":"Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice","volume":"141","author":"Redrobe","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb1150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: a stressful review","volume":"55","author":"Reichmann","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2004.10.084","article-title":"Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence","volume":"375","author":"Rimondini","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb1160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41386-018-0310-7","article-title":"Medial prefrontal cortex neuropeptide Y modulates binge-like ethanol consumption in C57BL\/6J mice","volume":"44","author":"Robinson","year":"2019","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj20020739","article-title":"Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform","volume":"369","author":"Rodriguez","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.npep.2023.102388_bb1170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.npep.2023.102388_bb1175","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1523\/JNEUROSCI.4220-08.2009","article-title":"Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer\u2019s disease","volume":"29","author":"Rose","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb1180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1530-0277.2002.tb02607.x","article-title":"The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure","volume":"26","author":"Roy","year":"2002","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb1185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.npep.2008.03.004","article-title":"Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats","volume":"42","author":"Rylkova","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2014.12.038","article-title":"Comparative effects of intranasal neuropeptide Y and HS014 in preventing anxiety and depressive-like behavior elicited by single prolonged stress","volume":"295","author":"Sabban","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb1195","article-title":"Potential benefits of intranasal neuropeptide Y include sustained extinction of fear memory","volume":"e13279","author":"Sabban","year":"2023","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.npep.2023.102388_bb1200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/mp.2012.101","article-title":"Neuropeptide y and posttraumatic stress disorder","volume":"18","author":"Sah","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb1205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2010.01.001","article-title":"Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways","volume":"44","author":"Sainsbury","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1210","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0028-3908(02)00234-4","article-title":"Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats","volume":"43","author":"Sajdyk","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102388_bb1215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0143-4179(95)90018-7","article-title":"Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats","volume":"29","author":"Sakai","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1220","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1038\/cddis.2013.160","article-title":"Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate","volume":"4","author":"Santos-Carvalho","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.npep.2023.102388_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110428","article-title":"Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: a postmortem study","volume":"112","author":"Sharma","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb1230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(04)15440-8","article-title":"Migraine","volume":"363","author":"Silberstein","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.npep.2023.102388_bb1235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-8981(02)00301-7","article-title":"Neuropeptide Y and its receptors as potential therapeutic drug targets","volume":"326","author":"Silva","year":"2002","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.npep.2023.102388_bb1240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1568007054546153","article-title":"The putative neuroprotective role of neuropeptide Y in the central nervous system","volume":"4","author":"Silva","year":"2005","journal-title":"Curr. Drug Targets. CNS Neurol. Disord."},{"key":"10.1016\/j.npep.2023.102388_bb1245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/rda.14281","article-title":"Genetic variants in 5\u2019UTR and exonic region of NPY gene alter the reproduction performance in Indian cattle breeds","volume":"58","author":"Singh","year":"2023","journal-title":"Reprod. Domest. Anim."},{"key":"10.1016\/j.npep.2023.102388_bb1250","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1177\/0333102417748928","article-title":"Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine","volume":"38","author":"Siva","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.npep.2023.102388_bb1255","article-title":"Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma","volume":"18","author":"Soleimani","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1260","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/syn.21568","article-title":"Mice lacking neuropeptide Y show increased sensitivity to cocaine","volume":"66","author":"S\u00f8rensen","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2023.102388_bb1265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pbb.2013.02.010","article-title":"Neuropeptide Y Y5 receptor antagonism causes faster extinction and attenuates reinstatement in cocaine-induced place preference","volume":"105","author":"S\u00f8rensen","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb1270","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/npp.2011.327","article-title":"Central neuropeptide Y modulates binge-like ethanol drinking in C57BL\/6J mice via Y1 and Y2 receptors","volume":"37","author":"Sparrow","year":"2012","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1275","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/01.ALC.0000139829.67958.1A","article-title":"Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL\/6J mice","volume":"28","author":"Sparta","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2023.102388_bb1280","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1074\/jbc.M115.678185","article-title":"Systemic Central Nervous System (CNS)-targeted delivery of neuropeptide Y (NPY) reduces neurodegeneration and increases neural precursor cell proliferation in a mouse model of Alzheimer Disease *","volume":"291","author":"Spencer","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb1285","first-page":"3","article-title":"Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review)","volume":"15","author":"Spinazzi","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.npep.2023.102388_bb1290","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1038\/npp.2013.146","article-title":"Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia","volume":"38","author":"Stadlbauer","year":"2013","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2014.04.006","article-title":"Neuropeptide Y, social function and long-term outcome in schizophrenia","volume":"156","author":"St\u00e5lberg","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.npep.2023.102388_bb1300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.21046","article-title":"Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals","volume":"499","author":"Stani\u0107","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb1305","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/bbrc.2000.3656","article-title":"Neuropeptide Y receptor Gene y6: multiple deaths or resurrections?","volume":"277","author":"Starb\u00e4ck","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2023.102388_bb1310","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/neu.2021.36","article-title":"Sirtuins and neuropeptide y downregulation in Flinders Sensitive Line rat model of depression","volume":"34","author":"Stiernborg","year":"2022","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.npep.2023.102388_bb1315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-4886(91)90080-V","article-title":"Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla","volume":"114","author":"Stoddard","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb1320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnins.2013.00029","article-title":"Interactions of zebrafish peptide YYb with the neuropeptide Y-family receptors Y4, Y7, Y8a, and Y8b","volume":"7","author":"Sundstr\u00f6m","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb1325","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1111\/febs.14607","article-title":"Determinants of dopaminergic neuron loss in Parkinson\u2019s disease","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.npep.2023.102388_bb1330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2017.00102","article-title":"Neuropeptide Y and calcitonin gene-related peptide in cerebrospinal fluid in Parkinson\u2019s disease with comorbid depression versus patients with major depressive disorder","volume":"8","author":"Svenningsson","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb1335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb1340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1468-2982.2001.00140.x","article-title":"Neuropeptide localization in the \u201cmigraine generator\u201d region of the human brainstem","volume":"21","author":"Tajti","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.npep.2023.102388_bb1345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147287","article-title":"The role of Neuropeptide Y in the nucleus accumbens","volume":"22","author":"Tanaka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2023.102388_bb1350","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s11671-021-03477-3","article-title":"HDAC1-mediated MicroRNA-124-5p regulates NPY to affect learning and memory abilities in rats with depression","volume":"16","author":"Tang","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb1355","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41467-021-21030-9","article-title":"Structural basis for ligand recognition of the neuropeptide Y Y2 receptor","volume":"12","author":"Tang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.npep.2023.102388_bb1360","doi-asserted-by":"crossref","first-page":"eabm1232","DOI":"10.1126\/sciadv.abm1232","article-title":"Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors","volume":"8","author":"Tang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.npep.2023.102388_bb1365","doi-asserted-by":"crossref","first-page":"eabm1232","DOI":"10.1126\/sciadv.abm1232","article-title":"Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors","volume":"8","author":"Tang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.npep.2023.102388_bb1370","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.npep.2023.102388_bb1375","series-title":"Your Anxious Child","first-page":"23","author":"The Eight Types of Anxiety Disorder","year":"2016"},{"key":"10.1016\/j.npep.2023.102388_bb1380","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/24614","article-title":"Ethanol consumption and resistance are inversely related to neuropeptide Y levels","volume":"396","author":"Thiele","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.npep.2023.102388_bb1385","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-3057(00)00413-5","article-title":"Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor","volume":"67","author":"Thiele","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb1390","doi-asserted-by":"crossref","first-page":"RC208","DOI":"10.1523\/JNEUROSCI.22-03-j0006.2002","article-title":"Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor","volume":"22","author":"Thiele","year":"2002","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb1395","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.peptides.2004.03.009","article-title":"Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice","volume":"25","author":"Thiele","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb1400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2004.04.005","article-title":"A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse","volume":"38","author":"Thiele","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1405","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1523\/JNEUROSCI.4893-04.2005","article-title":"Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum","volume":"25","author":"Thiriet","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.npep.2023.102388_bb1410","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1471-4159.2010.07154.x","article-title":"NPY promotes chemokinesis and neurogenesis in the rat subventricular zone","volume":"116","author":"Thiriet","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2023.102388_bb1415","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fendo.2017.00178","article-title":"Neuropeptide Y in alcohol addiction and affective disorders","volume":"8","author":"Thorsell","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.npep.2023.102388_bb1420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JCP.0b013e31827d145a","article-title":"Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients","volume":"33","author":"Tiwari","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1425","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.omtn.2017.06.019","article-title":"Antisense oligonucleotide-mediated removal of the polyglutamine repeat in spinocerebellar ataxia type 3 mice","volume":"8","author":"Toonen","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.npep.2023.102388_bb1430","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/YPG.0000000000000149","article-title":"Association between neuropeptide Y receptor Y2 promoter variant rs6857715 and major depressive disorder","volume":"27","author":"Treutlein","year":"2017","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.npep.2023.102388_bb1435","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/jnr.24589","article-title":"Neuropeptide Y in PTSD, MDD, and chronic stress: a systematic review and meta-analysis","volume":"98","author":"Tural","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2023.102388_bb1440","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bph.15326","article-title":"Increase in neuropeptide Y activity impairs social behaviour in association with glutamatergic dysregulation in diabetic mice","volume":"178","author":"Ueda","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102388_bb1445","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/08039488.2022.2048887","article-title":"The role of neuropeptide Y, orexin-A, and ghrelin in differentiating unipolar and bipolar depression: a preliminary study","volume":"76","author":"\u00dcnler","year":"2022","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb1450","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-510X(99)00316-0","article-title":"Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF","volume":"173","author":"Valenzuela","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.npep.2023.102388_bb1455","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2826.2012.02379.x","article-title":"Neuropeptide alterations in the infundibular nucleus of Huntington\u2019s disease patients","volume":"25","author":"van Wamelen","year":"2013","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.npep.2023.102388_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173071","article-title":"NPY-Y(1) receptors in dorsal periaqueductal gray modulate anxiety, alcohol intake, and relapse in Wistar rats","volume":"199","author":"V\u00e1zquez-Le\u00f3n","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102388_bb1465","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0361-9230(90)90229-S","article-title":"Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis","volume":"25","author":"V\u00e9csei","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2023.102388_bb1470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0143-4179(92)90065-5","article-title":"Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine","volume":"22","author":"V\u00e9csei","year":"1992","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1475","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nlm.2018.01.011","article-title":"Neuropeptide Y2 receptors in anteroventral BNST control remote fear memory depending on extinction training","volume":"149","author":"Verma","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.npep.2023.102388_bb1480","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jnc.13624","article-title":"Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington\u2019s Disease: increased NPY levels and differential degradation of the NPY1-30 fragment","volume":"137","author":"Wagner","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2023.102388_bb1485","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1073\/pnas.88.6.2078","article-title":"Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex","volume":"88","author":"Wahlestedt","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2023.102388_bb1490","first-page":"1235","article-title":"Association study between NPY and YWHAH gene polymorphisms and schizophrenia","volume":"32","author":"Wang","year":"2005","journal-title":"Yi Chuan Xue Bao"},{"key":"10.1016\/j.npep.2023.102388_bb1495","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-2007-992127","article-title":"No association of sequence variants in the neuropeptide Y2 receptor (NPY2R) gene with early onset obesity in Germans","volume":"39","author":"Wang","year":"2007","journal-title":"Horm. Metab. Res. = Horm. und Stoffwechselforsch. = Horm. Metab."},{"key":"10.1016\/j.npep.2023.102388_bb1500","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jacc.2009.05.035","article-title":"Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo","volume":"54","author":"Wang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.npep.2023.102388_bb1505","doi-asserted-by":"crossref","first-page":"7898095","DOI":"10.1155\/2019\/7898095","article-title":"NPY receptor 2 mediates NPY antidepressant effect in the mPFC of LPS Rat by suppressing NLRP3 signaling pathway","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.npep.2023.102388_bb1510","doi-asserted-by":"crossref","first-page":"108350","DOI":"10.1016\/j.neuropharm.2020.108350","article-title":"NPY alterations induced by chronic morphine exposure affect the maintenance and reinstatement of morphine conditioned place preference","volume":"181","author":"Wang","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102388_bb1515","doi-asserted-by":"crossref","first-page":"1012850","DOI":"10.3389\/fpsyt.2022.1012850","article-title":"The neuropeptide Y single-nucleotide polymorphism rs16147:T>C moderates the effect of alcohol dependence on depression in male Chinese Han population","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.npep.2023.102388_bb1520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033548","article-title":"Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain","volume":"7","author":"Weston-Green","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2023.102388_bb1525","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0022-3565(24)38069-3","article-title":"Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems","volume":"288","author":"Westwood","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2023.102388_bb1530","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/1475636021000005758","article-title":"8-Amino-5-nitro-6-phenoxyquinolines: potential non-peptidic neuropeptide Y receptor ligands","volume":"17","author":"Wielgosz-Collin","year":"2002","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.npep.2023.102388_bb1535","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2967\/jnumed.113.125351","article-title":"PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs","volume":"55","author":"Winterdahl","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.npep.2023.102388_bb1540","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.npep.2023.102388_bb1545","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(24)37249-0","article-title":"Neuropeptide Y attenuates Naloxone-Precipitated Morphine withdrawal via Y5-like receptors","volume":"284","author":"Woldbye","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2023.102388_bb1550","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s00429-015-1107-7","article-title":"Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala","volume":"221","author":"Wood","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.npep.2023.102388_bb1555","doi-asserted-by":"crossref","first-page":"113216","DOI":"10.1016\/j.expneurol.2020.113216","article-title":"Neuropeptide Y neurons in the nucleus accumbens modulate anxiety-like behavior","volume":"327","author":"Yamada","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb1560","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0038-1649502","article-title":"Multiple sclerosis","volume":"38","author":"Yamout","year":"2018","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.npep.2023.102388_bb1565","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41586-018-0046-x","article-title":"Structural basis of ligand binding modes at the neuropeptide y Y1 receptor","volume":"556","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.npep.2023.102388_bb1570","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s10194-023-01596-z","article-title":"Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor","volume":"24","author":"Yang","year":"2023","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.npep.2023.102388_bb1575","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(95)01343-1","article-title":"Methamphetamine stimulates the release of neuropeptide Y and noradrenaline from the paraventricular nucleus in rats","volume":"707","author":"Yoshihara","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102388_bb1580","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.npep.2013.10.002","article-title":"Neuropeptides and hippocampal neurogenesis","volume":"47","author":"Zaben","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2023.102388_bb1585","doi-asserted-by":"crossref","first-page":"135959","DOI":"10.1016\/j.neulet.2021.135959","article-title":"Mini-review: amyloid degradation toxicity hypothesis of Alzheimer\u2019s disease","volume":"756","author":"Zaretsky","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102388_bb1590","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.peptides.2003.08.008","article-title":"Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal","volume":"24","author":"Zhang","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102388_bb1595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00093-2","article-title":"Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells","volume":"87","author":"Zhang","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2023.102388_bb1600","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2011.03.011","article-title":"The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer","volume":"131","author":"Zhang","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.npep.2023.102388_bb1605","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature06858","article-title":"Genetic variation in human NPY expression affects stress response and emotion","volume":"452","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.npep.2023.102388_bb1610","series-title":"First Selective Agonist of the neuropeptide Y 1 -receptor with Reduced Size","first-page":"856","author":"Zwanziger","year":"2009"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417923000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417923000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:41:24Z","timestamp":1758919284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417923000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":322,"alternative-id":["S0143417923000690"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2023.102388","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross talk about the role of Neuropeptide Y in CNS disorders and diseases","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2023.102388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102388"}}